当前位置:首页 - 行情中心 - 贝达药业(300558) - 财务分析

贝达药业

(300558)

  

流通市值:210.12亿  总市值:210.79亿
流通股本:4.19亿   总股本:4.21亿

贝达药业(300558)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润2.31亿元,每股收益0.56元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益686263.63万元,未分配利润308126.68万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产1068827.29万元,负债382563.67万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入1,039,835,367.293,609,338,576.552,717,342,723.911,731,412,742.27
营业总成本777,633,137.593,158,280,259.832,301,749,460.621,494,357,686.84
其他经营收益
营业利润282,894,437.9418,382,880.55394,491,937.66188,147,769.79
利润总额282,468,142.66414,363,023.02391,574,046.96187,816,069.23
净利润231,159,602.66286,208,754.84303,006,092.01130,707,401.1
每股收益
其他综合收益-39,992,311.79709,253,597.7743,432,024.6-148,106,979.63
综合收益总额191,167,290.87995,462,352.61346,438,116.61-17,399,578.53
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计1,670,487,798.31,577,826,705.151,484,177,061.951,358,719,685.23
非流动资产:
非流动资产合计9,017,785,129.338,987,819,882.548,215,285,574.757,840,648,525.12
资产总计10,688,272,927.6310,565,646,587.699,699,462,636.79,199,368,210.35
流动负债:
流动负债合计1,686,428,885.841,917,279,973.21,927,160,477.241,756,546,635.1
非流动负债:
非流动负债合计2,139,207,789.141,980,683,132.711,852,740,722.271,765,342,827.01
负债合计3,825,636,674.983,897,963,105.913,779,901,199.513,521,889,462.11
所有者权益(或股东权益):
归属于母公司股东权益合计6,794,857,192.496,595,157,402.935,843,399,746.135,594,364,394.56
股东权益合计6,862,636,252.656,667,683,481.785,919,561,437.195,677,478,748.24
负债和股东权益合计10,688,272,927.6310,565,646,587.699,699,462,636.79,199,368,210.35
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计1,014,003,798.853,690,815,557.992,737,853,928.251,818,979,709.29
经营活动现金流出小计750,396,110.052,779,554,649.762,069,423,681.331,374,001,421.08
经营活动产生的现金流量净额263,607,688.8911,260,908.23668,430,246.92444,978,288.21
投资活动产生的现金流量:
投资活动现金流入小计40,051,689.81,074,286.071,013,509.4214,509.42
投资活动现金流出小计391,944,820.43928,939,783.05731,485,187.19391,306,234.66
投资活动产生的现金流量净额-351,893,130.63-927,865,496.98-730,471,677.77-391,291,725.24
筹资活动产生的现金流量:
筹资活动现金流入小计610,000,0001,009,946,278809,946,278672,166,278
筹资活动现金流出小计530,185,009.21,036,121,987.43807,159,708.6670,150,013.23
筹资活动产生的现金流量净额79,814,990.8-26,175,709.432,786,569.42,016,264.77
汇率变动对现金及现金等价物的影响-504,046.511,078,742.471,901,864.44-196,210.48
现金及现金等价物净增加额-8,974,497.54-41,701,555.71-57,352,997.0155,506,617.26
期末现金及现金等价物余额421,006,801.87429,981,299.41414,329,858.11527,189,472.38
补充资料:
现金及现金等价物的净增加额--41,701,555.71-55,506,617.26
最新报告期:2026-05-12
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
华创证券刘浩1.281.812.432026-05-12
长城国瑞证券胡晨曦,魏钰琪1.301.902.522026-04-30
国投证券冯俊曦,连国强1.431.802.232026-04-27
TOP↑